By Edward Winnick and Tony Fong

SAN FRANCISCO (GenomeWeb News) – The second day of the JP Morgan Conference included presentations from several of molecular tools and molecular diagnostics bellwethers, including Thermo Fisher Scientific and Qiagen, as well as single-molecule sequencing firm Pacific Biosciences.

Below is a recap of their pitches to investors and other issues discussed during their breakout sessions.

Thermo Fisher Scientific

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.